Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Medulloblastoma and CTNNB1[original query] |
---|
APC and CTNNB1 mutations are rare in sporadic ependymomas. Cancer genetics and cytogenetics 2006 Jul 168 (2): 158-61. Onilude Olabisi E, Lusher Meryl E, Lindsey Janet C, Pearson Andrew D J, Ellison David W, Clifford Steven |
TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Dec 28 (35): 5188-96. Pfaff Elke, Remke Marc, Sturm Dominik, Benner Axel, Witt Hendrik, Milde Till, von Bueren André O, Wittmann Andrea, Schöttler Anna, Jorch Norbert, Graf Norbert, Kulozik Andreas E, Witt Olaf, Scheurlen Wolfram, von Deimling Andreas, Rutkowski Stefan, Taylor Michael D, Tabori Uri, Lichter Peter, Korshunov Andrey, Pfister Stefan |
CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma. Journal of neuro-oncology 2015 Aug . Dahlin Anna M, Hollegaard Mads V, Wibom Carl, Andersson Ulrika, Hougaard David M, Deltour Isabelle, Hjalmars Ulf, Melin Beatri |
Identification of a novel inherited ALK variant M1199L in the WNT type of medulloblastoma. Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2016 54 (1): 23-30. Trubicka J, Szperl M, Grajkowska W, Karkuci?ska-Wi?ckowska A, Tarasi?ska M, Falana K, Dembowska-Bagi?ska B, ?astowska |
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 1 39 (7): 822-835. Gajjar Amar, Robinson Giles W, Smith Kyle S, Lin Tong, Merchant Thomas E, Chintagumpala Murali, Mahajan Anita, Su Jack, Bouffet Eric, Bartels Ute, Schechter Tal, Hassall Tim, Robertson Thomas, Nicholls Wayne, Gururangan Sridharan, Schroeder Kristin, Sullivan Michael, Wheeler Greg, Hansford Jordan R, Kellie Stewart J, McCowage Geoffrey, Cohn Richard, Fisher Michael J, Krasin Matthew J, Stewart Clinton F, Broniscer Alberto, Buchhalter Ivo, Tatevossian Ruth G, Orr Brent A, Neale Geoff, Klimo Paul, Boop Frederick, Srinivasan Ashok, Pfister Stefan M, Gilbertson Richard J, Onar-Thomas Arzu, Ellison David W, Northcott Paul |
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas. Acta neuropathologica 2022 Oct . Goschzik Tobias, Mynarek Martin, Doerner Evelyn, Schenk Alina, Spier Isabel, Warmuth-Metz Monika, Bison Brigitte, Obrecht Denise, Struve Nina, Kortmann Rolf-Dieter, Schmid Matthias, Aretz Stefan, Rutkowski Stefan, Pietsch Torst |
MYC promotes aggressive growth and metastasis of a WNT-medulloblastoma mouse model. Developmental neuroscience 2023 8 . Rachel Hartley, Timothy N Phoen |
First report of medulloblastoma in a patient with MUTYH-associated polyposis. Neuropathology and applied neurobiology 2023 7 e12929. Marie-Charlotte Villy, Mathilde Warcoin, Mathilde Filser, Bruno Buecher, Lisa Golmard, Voreak Suybeng, Mathias Schwartz, Ivan Bieche, Sophie Vacher, Valérie Laurence, Franck Bourdeaut, Michèle Bernier, Tom Gutman, Dominique Stoppa-Lyonnet, Julien Masliah-Planchon, Chrystelle Col |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: